November 16, 2021 by Chain Drug Review
Cardinal Health
Leading Headlines, Pharmacy

DUBLIN, Ohio — According to a story in today’s Wall Street Journal, Cardinal Health plans to test the use of drones with Zipline International Inc. to deliver medications, inhalers and other items to U.S. pharmacies – with the goal of saving time and transport costs. Pending Federal Aviation Administration approvals, the pilot program will begin
November 9, 2021 by Chain Drug Review
Cardinal Health
Business, Leading Headlines

DUBLIN, Ohio — Cardinal Health reported first quarter fiscal year 2022 revenues of $44.0 billion, an increase of 13% from the first quarter of last year. First quarter GAAP operating earnings were $415 million and GAAP diluted earnings per share (EPS) were $0.94. Prior year first quarter GAAP results included an operating loss of $624 million due to a $1.0 billion pretax
October 11, 2021 by Chain Drug Review
Cardinal Health, NCPA CEO B. Douglas Hoey, The 2021 NCPA Digest
Leading Headlines, Pharmacy

CHARLOTTE, N.C. – The 2021 NCPA Digest, sponsored by Cardinal Health, was released Monday as part of the National Community Pharmacists Association’s Annual Convention. The NCPA Digest, which provides an annual overview of independent community pharmacy, found that the industry in 2020 represented 34% of all retail pharmacies in the United States and a $67.1 billion marketplace. “In
October 6, 2021 by Chain Drug Review
Cardinal Health
Leading Headlines, Pharmacy

DUBLIN, Ohio — While demand for rheumatology care continues to grow, rheumatologists are feeling pressured by reimbursement changes, administrative duties and workforce shortages. These findings were released today in the latest edition of Rheumatology Insights, a research-based report published by Cardinal Health Specialty Solutions. Based on surveys with more than 85 U.S. rheumatologists, Rheumatology Insights focuses on key trends
August 27, 2021 by Chain Drug Review
Cardinal Health, RE ELiT
Leading Headlines, Pharmacy

DUBLIN, Ohio – Cardinal Health and IRE ELiT (the radiopharmaceutical subsidiary of IRE Group) are working to expand patient access to novel radiopharmaceuticals for Positron Emission Tomography (PET) imaging as demand in the United States (U.S.) continues to grow. Cardinal Health is the preferred U.S. distributor of the IRE ELiT 100 mCi Germanium-68/Gallium-68 radionuclide generator
August 23, 2021 by Chain Drug Review
Cardinal Health
Leading Headlines, Pharmacy

DUBLIN, Ohio — Cardinal Health announced on Monday a comprehensive talent strategy to increase representation of diverse employees at the manager level and above by 2030. This commitment is specifically aimed at increasing the company’s global leadership representation of women, as well as African American and Black, Asian, Latinx, Indigenous and all other ethnically diverse
August 12, 2021 by Chain Drug Review
Cardinal Health
Leading Headlines, Pharmacy

DUBLIN, Ohio – TerraPower and Cardinal Health announced an agreement that will help advance the next generation of cancer treatment. Under the agreement, the companies will work together to develop and produce Actinium-225 for use in drug development and commercial sales. “Through TerraPower Isotopes, our team harnesses our focus on nuclear science and innovation and
August 11, 2021 by Chain Drug Review
Cardinal Health, CEO Mike Kaufmann, CVS Health
Featured Articles, Leading Headlines, Pharmacy

DUBLIN, Ohio — Cardinal Health announced Wednesday that it has extended its agreements with CVS Health to distribute pharmaceuticals to retail pharmacies and distribution centers through June 30, 2027. “We value our long-standing partnership with CVS Health, and we are honored to continue our important work together to bring our best-in-class abilities together for their
August 10, 2021 by Chain Drug Review
Cardinal Health
Leading Headlines, Pharmacy

DUBLIN, Ohio — Cardinal Health has created an interactive tool that provides pharmacists with key guidance to help them navigate the recent Food and Drug Administration (FDA) approval of the first interchangeable biologic licensed in the U.S. The FDA approval was given to the long-acting insulin called Semglee (insulin glargine-yfgn), which is now designated as
August 10, 2021 by Chain Drug Review
Abbott, Cardinal Health, COVID-19 tests
Leading Headlines, Pharmacy

DUBLIN, Ohio — Cardinal Health announced on Tuesday its efforts to commercialize and broaden access to over-the-counter rapid COVID-19 tests through partnerships with Abbott and Quidel Corp. Cardinal Health will leverage its expansive distribution network to support broad access to Quidel’s QuickVue At-Home OTC COVID-19 Test and Abbott’s BinaxNOW COVID-19 Antigen Self-Test, which allow consumers
August 2, 2021 by Chain Drug Review
Cardinal Health, Cordis
Leading Headlines, Pharmacy

DUBLIN, Ohio — Cardinal Health and Hellman & Friedman (H&F) announced Monday the completion of the previously announced sale of Cardinal Health’s Cordis business to H&F. The sale price of approximately $1 billion includes the buyer’s assumption of certain liabilities and the seller’s retention of certain working capital accounts. “We appreciate H&F’s partnership throughout the transaction,
July 30, 2021 by Chain Drug Review
Cardinal Health
Leading Headlines, Pharmacy

DUBLIN, Ohio – Cardinal Health WaveMark Supply Management & Workflow Solutions has released a whitepaper outlining how automated solutions for inventory management can mitigate supply chain operational issues. Using data from health systems that currently use Wavemark, the whitepaper shows how the business improved key health system metrics and outcomes. According to the findings, supply
July 15, 2021 by Chain Drug Review
Cardinal Health, E-Commerce Storefront, NavixRx Compliance Packaging
Leading Headlines, Pharmacy

DUBLIN, Ohio — Cardinal Health launched on Thursday two new innovative solutions – Cardinal Health NavixRx Compliance Packaging and E-Commerce Storefront – to help independent pharmacies meet changing consumer expectations and offer personalized and convenient on-demand services. NavixRx Compliance Packaging provides independent pharmacies a solution to outsource compliance packaging for patients taking two or more
July 2, 2021 by Chain Drug Review
Cardinal Health, Cardinal Health OptiFreight Logistic
Leading Headlines, Pharmacy

DUBLIN, Ohio — Last year, a critical need for life-saving blood and plasma donations arose with two major complications: an extraordinary decrease in blood donations due to the COVID-19 pandemic, and pandemic-related constraints to the healthcare supply chain, particularly in transportation logistics. “Many health care systems use multiple carriers or couriers to deliver shipments, and can’t